Skip to main content

Table 2 Details of included studies

From: Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review

Author/Ref.

Year/country

Previous therapy

Group

No.

Median age

Gender (M:F)

Interventions

Median follow-up time (m)

Chao Zou

2015

Resection + TACE

IFN

102

53

91:11

IFN

Control

126

52

113:13

IFN + TACE.

Li N

2010

Resection

IFN

43

53.2

31:12

IFN

Control

36

51.2

26:10

ST

Sun, HC

2006 China

Resection

IFN

118

52.2

106:12

IFN

36.5

Control

118

50.4

102:16

ST

Lo, CM

2007 China

Resection

IFN

40

49

31:9

IFN

Minimum follow-up 30

Control

40

54

34:6

ST

Li, MQ

2009 China

TACE

IFN

108

NA

77:31

IFN

24.8

Control

108

NA

74:34

ST

Chen, LT

2012 China

Resection

IFN

133

NA

108:25

IFN

63.8 (60.8–66.9)

Control

135

NA

112:23

ST

  1. TACE transarterial chemoembolization, ST symptomatic treatment